Dr. Nijhawan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8951Fax+1 214-645-2405
Summary
- Rajiv Nijhawan, MD, is a dermatologist based in Dallas, TX, specializing in cosmetic dermatology and dermatologic surgery. He earned his medical degree from the University of Miami Leonard M. Miller School of Medicine in 2009 and completed his dermatology residency at the Icahn School of Medicine at Mount Sinai from 2013 to 2016. Dr. Nijhawan has expertise in dermatologic surgery, cosmetic dermatology, Mohs micrographic surgery, and melanoma and cutaneous malignancies. His recent publications include studies on proliferating pilar tumors, cutaneous malignancy in chronic lymphocytic leukemia, multiple primary cancers in atypical fibroxanthoma, an overview of Mohs micrographic surgery, and risk factors for metastatic squamous cell carcinoma in organ transplant recipients.
Education & Training
- Icahn School of Medicine at Mount SinaiResidency, Dermatology, 2009 - 2013
- University of Miami Leonard M. Miller School of MedicineClass of 2009, M.D.
Certifications & Licensure
- TX State Medical License 2014 - 2025
- NY State Medical License 2013 - 2015
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Mohs Micrographic Surgery: The Past 25 Years.Rajiv I Nijhawan, Divya Srivastava, Marc Brown, Hugh Greenway, Désirée Ratner
Dermatologic Surgery. 2025-03-01 - Evaluation of online education for skin cancer prevention in organ transplant recipients.Robert P Bower, Rajiv I Nijhawan, Bryan Carroll, Elizabeth Billingsley, Amrit Greene
Archives of Dermatological Research. 2025-02-22 - Histologic distinction and potential misidentification of proliferating pilar tumors versus squamous cell carcinoma.William Chai, Michael Nemeh, David Silvers, Rajiv I Nijhawan
Journal of the American Academy of Dermatology. 2024-12-20
Journal Articles
- Pharmacogenomics of Fluoropyrimidines—a Personalized Approach for Treating and Preventing Keratinocyte Carcinomas—ReplyRajiv Nijhawan, MD, JAMA Dermatology
- Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell CarcinomaRajiv Nijhawan, MD, JAMA Dermatology
Authored Content
- Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell CarcinomaJuly 2020
Press Mentions
- 6 Skin Biopsy Wound Care Tips from DermatologistsMay 31st, 2022
- Whatever Your Skin Tone, Spread on the SunscreenJune 26th, 2017
- Dallas Cowboys, American Academy of Dermatology Unite to Tackle Skin CancerFebruary 12th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: